[HTML][HTML] Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants
…, A Marçais, T Barba, V Mathias, A Sicard… - Nature …, 2019 - nature.com
Current doctrine is that microvascular inflammation (MVI) triggered by a transplant -recipient
antibody response against alloantigens (antibody-mediated rejection) is the main cause of …
antibody response against alloantigens (antibody-mediated rejection) is the main cause of …
Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss
A Sicard, S Ducreux, M Rabeyrin, L Couzi… - Journal of the …, 2015 - journals.lww.com
Antibody-mediated rejection (AMR) is a major cause of kidney graft loss, yet assessment of
individual risk at diagnosis is impeded by the lack of a reliable prognosis assay. Here, we …
individual risk at diagnosis is impeded by the lack of a reliable prognosis assay. Here, we …
[HTML][HTML] Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients
A Sicard, C Lamarche, M Speck, M Wong… - American Journal of …, 2020 - Elsevier
Cell therapy with autologous donor-specific regulatory T cells (Tregs) is a promising strategy
to minimize immunosuppression in transplant recipients. Chimeric antigen receptor (CAR) …
to minimize immunosuppression in transplant recipients. Chimeric antigen receptor (CAR) …
[HTML][HTML] Mature IgM-expressing plasma cells sense antigen and develop competence for cytokine production upon antigenic challenge
…, T Fest, M Taillardet, O Thaunat, A Sicard… - Nature …, 2016 - nature.com
Dogma holds that plasma cells, as opposed to B cells, cannot bind antigen because they have
switched from expression of membrane-bound immunoglobulins (Ig) that constitute the B-…
switched from expression of membrane-bound immunoglobulins (Ig) that constitute the B-…
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
…, N Kamar, P Gatault, R Snanoudj, A Sicard… - Kidney international, 2020 - Elsevier
Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …
Is COVID‐19 infection more severe in kidney transplant recipients?
…, R Snanoudj, C Colosio, A Sicard… - American Journal of …, 2021 - Wiley Online Library
There are no studies which have compared the risk of severe COVID‐19 and related mortality
between transplant recipients and nontransplant patients. We enrolled two groups of …
between transplant recipients and nontransplant patients. We enrolled two groups of …
Occurrence of severe COVID-19 in vaccinated transplant patients
…, C Masset, M Hazzan, P Gatault, A Sicard… - Kidney …, 2021 - kidney-international.org
1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19
vaccine. N Engl J Med. 2020; 383: 2603-2615. 2. Baden LR, El Sahly HM, Essink B, et al. …
vaccine. N Engl J Med. 2020; 383: 2603-2615. 2. Baden LR, El Sahly HM, Essink B, et al. …
[HTML][HTML] Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients
…, B Seitz-Polski, N Glaichenhaus, A Sicard - …, 2021 - thelancet.com
Background The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in
kidney transplant (KT) recipients. Here, we provide a thorough assessment of the …
kidney transplant (KT) recipients. Here, we provide a thorough assessment of the …
IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)
…, C Mariat, A Thierry, M Le Quintrec, A Sicard… - Kidney international, 2020 - Elsevier
End stage kidney disease increase the risk of COVID-19 related death but how the kidney
replacement strategy should be adapted during the pandemic is unknown. Chronic …
replacement strategy should be adapted during the pandemic is unknown. Chronic …
Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody …
…, T Barba, V Mathias, A Sicard… - Journal of the …, 2021 - journals.lww.com
Background Binding of donor-specific antibodies (DSAs) to kidney allograft endothelial cells
that does not activate the classic complement cascade can trigger the recruitment of innate …
that does not activate the classic complement cascade can trigger the recruitment of innate …